Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2000-12-21
2002-08-27
Reamer, James H. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
06440983
ABSTRACT:
TECHNICAL FIELD
The present invention relates broadly to the field of healthcare, and in particular, to the treatment of severe headaches in human beings. More specifically, this invention relates to compositions and methods for providing relief from the symptoms of migraine headaches and/or cluster headaches and/or headaches related to sinus congestion, in affected individuals who also have a low tolerance for aspirin due to digestive disorders.
BACKGROUND OF THE INVENTION
Migraine is a particularly painful headache, which recurs and can be physically debilitating to sufferers. In many respects, cluster headaches are similar to migraine headaches, and all references herein to migraine and/or migraine headaches shall be considered as also including, and as references to, cluster headaches. There is no single cause or remedy for migraine headaches, and the incidence of migraine appears to be increasing in the general population. Although sufferers, on average, experience only one attack per month, each attack can last between four and seventy-two hours. In some cases, sufferers experience a pre-onset “warning” which may indicate that a migraine is imminent, and which may be termed an “aura.” An “aura” is a disruption of brain function characterized by visual disturbances like flashing lights and blurred vision. These “disruptions” occur twenty to thirty minutes before an attack. About twenty percent of migraine suffers experience “aura” symptoms. Other attacks can be preceded by a “prodrome” several hours before the onset of a migraine. These “prodrome” symptoms may include, but are not limited to, fatigue, yawning, sensory sensitivity, mood changes, and food cravings.
Prescription medications have previously been developed to alleviate the severity of migraine pain, but prescription migraine medications generally contain some type of narcotic, which, over time, may become addictive. Although over-the-counter remedies also exist, marketed under the EXCEDRIN® and ADVIL® brands, the EXCEDRIN® Migraine Formula contains aspirin, acetaminophen, and caffeine as its active ingredients, while the only active ingredient of the ADVIL® Migraine product is ibuprofen. Many migraine sufferers cannot take aspirin, due to digestive disorders, such as acid reflux disease, ulcers, and acid indigestion, and for many such sufferers, ibuprofen alone is not sufficient to lessen the pain or to reduce it to a manageable level. It would therefore be desirable to provide a non-prescription remedy which alleviates migraine symptoms in a manner not accomplished by the currently available “over-the-counter” remedies.
Sinus congestion (sinusitis) is also a cause of severe headaches, which can produce some of the same symptoms as migraine, such as nausea, vomiting, severe pain, and sensitivity to light, and severe sinus headache sufferers can sometimes experience “aura” and/or “prodrome” symptoms as well. Current over-the-counter remedies specifically formulated to treat severe sinus headaches contain antihistamines and decongestants, in addition to analgesics. However, antihistamines provide relief only if sinusitis is caused by an allergy, and although a decongestant can be helpful, it also can worsen the symptoms if the sinusitis does not result from infection or is acute, because a decongestant will dry up the mucous membranes and can cause further impaction of the sinus cavities.
In the case of chronic sinusitis, an expectorant may be more helpful by liquefying the mucous and allowing the sinus cavities to drain, thereby relieving the pressure contributing to severe sinus headache. Expectorants are commonly used in over-the-counter medicines, but primarily in the treatment of coughs and chest congestion, not for sinus pain relief.
No currently available over-the-counter remedy provides for an expectorant combined with relief from the migraine-like symptoms of severe sinus headache, and it would therefore be desirable to provide a non-narcotic, non-prescription remedy which alleviates those symptoms, without the use of a decongestant or an antihistamine, in a manner not accomplished by the currently available over-the-counter remedies.
Recent research and clinical trials suggest that the mineral magnesium can provide some relief from migraine symptoms, at least in sufferers who have a measurable magnesium deficiency. A large percentage of the population of sufferers may indeed show this deficiency, which may contribute to migraine onset, and sufferers of severe sinus headache may exhibit this deficiency as well. Thus, an over-the-counter remedy for cluster and/or migraine headache should address potential magnesium deficiency and sensitivity to aspirin, but should also be strong enough to provide relief, and an over-the-counter remedy for severe sinus headache should address congested and impacted sinus cavities as well. The present invention is directed to meeting one or more of the above-stated desirable objectives.
SUMMARY OF THE INVENTION
The invention provides compositions, in pharmaceutically effective forms and amounts, as well as methods, for treating both migraine/cluster headaches and severe sinus headaches, in human beings in need of such treatment.
In accordance with one aspect of the invention, a migraine/cluster headache remedy is provided by combining a pain-masking analgesic (such as acetaminophen), a nonsteroidal anti-inflammatory agent (such as ibuprofen), a central nervous system stimulant (such as caffeine), and magnesium.
A feature of this aspect of the invention is that it provides pain relief through the combination of acetaminophen and ibuprofen, neither of which contains any aspirin.
Another feature of this aspect of the invention is the inclusion of the mineral magnesium as an active ingredient to remedy severe headache. This mineral ingredient advantageously addresses magnesium deficiency and its link to migraine/cluster headache cause.
In accordance with another aspect of the invention, a severe sinus headache remedy is provided by combining an expectorant (such as guaifenesin) with a pain-masking analgesic (such as acetaminophen), a nonsteroidal anti-inflammatory agent (such as ibuprofen), a central nervous system stimulant (such as caffeine), and magnesium.
A feature of this aspect of the invention, in addition to the features set forth above, is that it provides an expectorant (guaifenesin) as a means for inducing drainage of mucous secretions from the sinus passageways, without using a decongestant or antihistamine.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
In accordance with a first embodiment of the invention, the combination of four active ingredients namely, acetaminophen, ibuprofen, caffeine and magnesium, in a pharmaceutically-acceptable form and in therapeutically-effective dosage, provides strong pain relief for sufferers of migraine/cluster headaches. Generally, these ingredients are utilized in the following amounts for a single dose: 100-500 mg. of acetaminophen, 100-500 mg. of ibuprofen, 25-150 mg. of caffeine and 100-500 mg. of magnesium. Preferably, the following amounts of these ingredients are used: 200-400 mg. of acetaminophen, 200-400 mg. of ibuprofen, 50-100 mg. of caffeine and 150-400 mg. of magnesium. Most preferably, the inventive composition comprises the following amounts of these ingredients: approximately 250 mg. of acetaminophen, approximately 250 mg. of ibuprofen, approximately 75 mg. of caffeine and approximately 250 mg. of magnesium.
In accordance with a second embodiment of the invention, the combination of five active ingredients, namely, guaifenesin, acetaminophen, ibuprofen, caffeine and magnesium, in a pharmaceutically-acceptable form and in a therapeutically-effective dosage, provides strong pain relief as well as sinus drainage for sufferers of severe sinus headaches. Generally, these ingredients are utilized in the following amounts for a single dose: 200-400 mg. of guaifenesin, 100-500 mg. of acetaminophen, 100-500 mg. of ibuprofen, 25-150 mg. of caffeine and 100-500 mg. of magnesium. Preferably, the following amounts of these
Gottlieb Rackman & Reisman
Reamer James H.
LandOfFree
Compositions and methods for relieving headache symptoms in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for relieving headache symptoms in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for relieving headache symptoms in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2911082